Laboratorios Farmaceuticos Rovi Stock Analysis

Laboratorios Pink Sheet Analysis Notes

About 60.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 5th of July 2022. Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. Laboratorios Farmaceticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L. Laboratorios Farmaceuticos operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1852 people.The quote for Laboratorios Farmaceuticos Rovi is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Laboratorios Farmaceuticos Rovi contact Juan Encina at 34 91 021 30 00 or learn more at https://www.rovi.es.

Laboratorios Farmaceuticos Investment Alerts

Laboratorios Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.62 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Laboratorios Farmaceuticos's market, we take the total number of its shares issued and multiply it by Laboratorios Farmaceuticos's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Laboratorios Profitablity

The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.28 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.28.

Technical Drivers

In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Laboratorios Farmaceuticos, as well as the relationship between them.

Laboratorios Farmaceuticos Price Movement Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Laboratorios Farmaceuticos prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Laboratorios shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Laboratorios Farmaceuticos. By using and applying Laboratorios Pink Sheet analysis, traders can create a robust methodology for identifying Laboratorios entry and exit points for their positions.

When running Laboratorios Farmaceuticos' price analysis, check to measure Laboratorios Farmaceuticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Farmaceuticos is operating at the current time. Most of Laboratorios Farmaceuticos' value examination focuses on studying past and present price action to predict the probability of Laboratorios Farmaceuticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Farmaceuticos' price. Additionally, you may evaluate how the addition of Laboratorios Farmaceuticos to your portfolios can decrease your overall portfolio volatility.